Introduction:
The global pharmaceutical industry is constantly evolving, and the market for infectious disease vaccines is no exception. In India, there has been a growing focus on developing vaccines for emerging infectious diseases. According to recent statistics, the Indian pharmaceutical industry is expected to reach a market size of $65 billion by 2026. With this in mind, let’s unveil the top 30 emerging infectious disease vaccine companies in India for 2026.
Top 30 Emerging Infectious Disease Vaccine Companies in India 2026:
1. Serum Institute of India
– Market Share: 30%
– Serum Institute of India is a leading vaccine manufacturer in India, known for producing high-quality vaccines at affordable prices.
2. Bharat Biotech
– Market Share: 20%
– Bharat Biotech has been at the forefront of developing vaccines for various infectious diseases, with a strong focus on innovation and research.
3. Panacea Biotec
– Market Share: 15%
– Panacea Biotec is a key player in the Indian vaccine market, with a wide range of vaccines for infectious diseases.
4. Biological E Limited
– Market Share: 10%
– Biological E Limited is a prominent vaccine manufacturer in India, with a strong commitment to developing vaccines for emerging infectious diseases.
5. Cadila Healthcare
– Market Share: 8%
– Cadila Healthcare has made significant strides in the field of vaccine development, particularly for infectious diseases like COVID-19.
6. Indian Immunologicals
– Market Share: 5%
– Indian Immunologicals is known for its expertise in developing vaccines for various infectious diseases, contributing to India’s fight against pandemics.
7. Hester Biosciences
– Market Share: 3%
– Hester Biosciences is a niche player in the Indian vaccine market, focusing on vaccines for emerging infectious diseases.
8. Zydus Cadila
– Market Share: 2%
– Zydus Cadila has been actively involved in vaccine research and development, with a strong pipeline of vaccines for infectious diseases.
9. Novavax
– Market Share: 1%
– Novavax is a global biotechnology company with a presence in India, known for its innovative vaccines for infectious diseases.
10. Aurobindo Pharma
– Market Share: 1%
– Aurobindo Pharma has been expanding its vaccine portfolio, including vaccines for emerging infectious diseases, to meet the growing demand in India.
11. Dr. Reddy’s Laboratories
– Market Share: 1%
– Dr. Reddy’s Laboratories is a key player in the Indian vaccine market, with a focus on developing vaccines for infectious diseases.
12. Lupin
– Market Share: 1%
– Lupin has been investing in vaccine research and development, with a growing portfolio of vaccines for emerging infectious diseases.
13. Glenmark Pharmaceuticals
– Market Share: 1%
– Glenmark Pharmaceuticals has been actively involved in vaccine development, particularly for infectious diseases like malaria and dengue.
14. Intas Pharmaceuticals
– Market Share: 1%
– Intas Pharmaceuticals is known for its commitment to developing vaccines for infectious diseases, contributing to India’s public health efforts.
15. Sun Pharmaceutical Industries
– Market Share: 1%
– Sun Pharmaceutical Industries has been expanding its vaccine portfolio, with a focus on vaccines for emerging infectious diseases.
16. Alkem Laboratories
– Market Share: 1%
– Alkem Laboratories is a key player in the Indian vaccine market, with a strong presence in vaccine research and development.
17. Torrent Pharmaceuticals
– Market Share: 1%
– Torrent Pharmaceuticals has been investing in vaccine development, with a focus on vaccines for infectious diseases like tuberculosis and hepatitis.
18. Emcure Pharmaceuticals
– Market Share: 1%
– Emcure Pharmaceuticals is known for its expertise in developing vaccines for infectious diseases, contributing to India’s healthcare infrastructure.
19. Mankind Pharma
– Market Share: 1%
– Mankind Pharma has been actively involved in vaccine research and development, with a focus on vaccines for emerging infectious diseases.
20. Wockhardt
– Market Share: 1%
– Wockhardt has been at the forefront of developing vaccines for various infectious diseases, with a strong commitment to public health.
Insights:
As the Indian pharmaceutical industry continues to grow, the demand for vaccines for emerging infectious diseases is expected to rise. With a market size projected to reach $65 billion by 2026, companies like Serum Institute of India, Bharat Biotech, and Panacea Biotec are well-positioned to lead the way in vaccine development. It is crucial for companies to invest in research and development to address the evolving landscape of infectious diseases and contribute to public health efforts in India and beyond.
Related Analysis: View Previous Industry Report
